Dexcom (DXCM) Current Deferred Revenue (2010 - 2025)
Dexcom (DXCM) reported Current Deferred Revenue of $2.9 million for Q3 2025, down 79.14% year-over-year from $13.9 million in Q3 2024, and down 52.46% on a QoQ basis from $6.1 million in Q2 2025.
Dexcom (DXCM) has 16 years of Current Deferred Revenue data on file, last reported at $2.9 million in Q3 2025.
- Quarterly Current Deferred Revenue fell 79.14% year-over-year to $2.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.9 million (down 79.14% YoY) and the FY2024 annual result came in at $8.0 million, down 56.52% from the prior year.
- Current Deferred Revenue declined to $2.9 million in Q3 2025 per DXCM's latest filing, from $6.1 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $18.4 million in Q4 2023 and bottomed at $1.8 million in Q2 2021.
- The 5-year median for Current Deferred Revenue is $7.8 million (2025), against an average of $7.5 million.
- The widest annual swing landed in 2022, when Current Deferred Revenue jumped 380.95%; it then tumbled 79.14% in 2025.
- Tracing DXCM's Current Deferred Revenue over 5 years: stood at $2.1 million in 2021, then jumped by 380.95% to $10.1 million in 2022, then jumped by 82.18% to $18.4 million in 2023, then sank by 56.52% to $8.0 million in 2024, then plunged by 63.75% to $2.9 million in 2025.
- Per Business Quant, the three latest DXCM Current Deferred Revenue figures stand at $2.9 million (Q3 2025), $6.1 million (Q2 2025), and $7.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 13.90 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Mar 31, 2024 | 16.40 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 10.10 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.80 Mn |
| Mar 31, 2021 | 1.90 Mn |
| Dec 31, 2020 | 2.20 Mn |
| Sep 30, 2020 | 1.50 Mn |
| Jun 30, 2020 | 1.70 Mn |
| Mar 31, 2020 | 1.80 Mn |
| Dec 31, 2019 | 1.70 Mn |
| Sep 30, 2019 | 4.30 Mn |
| Jun 30, 2019 | 3.50 Mn |
| Mar 31, 2019 | 2.70 Mn |
| Dec 31, 2018 | 2.90 Mn |
| Sep 30, 2018 | 3.50 Mn |
| Jun 30, 2018 | 6.80 Mn |
| Mar 31, 2018 | 2.90 Mn |
| Dec 31, 2017 | 3.20 Mn |
| Sep 30, 2017 | 2.30 Mn |
| Jun 30, 2017 | 1.50 Mn |
| Mar 31, 2017 | 1.20 Mn |
| Dec 31, 2016 | 900,000.00 |
| Sep 30, 2016 | 500,000.00 |
| Jun 30, 2016 | 700,000.00 |
| Mar 31, 2016 | 600,000.00 |
| Dec 31, 2015 | 800,000.00 |
| Sep 30, 2015 | 1.60 Mn |
| Jun 30, 2015 | 800,000.00 |
| Mar 31, 2015 | 1.30 Mn |
| Dec 31, 2014 | 700,000.00 |
| Sep 30, 2014 | 600,000.00 |
| Jun 30, 2014 | 300,000.00 |
| Mar 31, 2014 | 600,000.00 |
| Dec 31, 2013 | 700,000.00 |
| Sep 30, 2013 | 600,000.00 |
| Jun 30, 2013 | 700,000.00 |
| Mar 31, 2013 | 800,000.00 |
| Dec 31, 2012 | 1.40 Mn |
| Sep 30, 2012 | 1.22 Mn |
| Jun 30, 2012 | 1.50 Mn |
| Mar 31, 2012 | 1.85 Mn |
| Dec 31, 2011 | 1.60 Mn |
| Sep 30, 2011 | 1.74 Mn |
| Jun 30, 2011 | 2.33 Mn |
| Dec 31, 2010 | 3.52 Mn |